Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP)
Clinical trial NCT00718692 · COMPLETED
Trial details
- NCT number
- NCT00718692
- Sponsor
- Symphogen A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2011-08-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.